RHON-KLINIKUM AG has announced a stable business performance for the first half of 2026, with consolidated revenue reaching EUR 863.6 million, slightly above the prior year's EUR 833.5 million. EBITDA improved to EUR 57.0 million from EUR 46.7 million, and consolidated profit rose to EUR 22.5 million compared to EUR 14.7 million in H1 2025. The company treated 513,700 patients on an outpatient and inpatient basis, marking a 9% increase from 471,295 in the same period last year.
The positive results were partly offset by immediate transformation costs established to counter higher personnel and material expenses from previous years. Despite these costs, the company continues to invest in expanding regional health networks, a strategic focus that management believes is essential for future healthcare delivery. For instance, Universitatsklinikum Marburg and Lungenfachklinik Immenhausen have formed a partnership to enhance lung patient care, while a new child protection emergency service at the Frankfurt (Oder) site has been launched with cooperation agreements involving the city and district.
Dr. Gunther K. WeiB, member of the Board of Management, emphasized the importance of regional networks: "Regional networks form a vital and essential part of any future healthcare system. Rigid sectoral boundaries make it more difficult to provide patients with the care they need and saddle our healthcare system with unnecessary costs. It is only when general practitioners, specialists, medical facilities, nurses and therapists work together as a team that we can pool our resources efficiently."
However, the company faces significant regulatory headwinds. Dr. Stefan Stranz, also on the Board, criticized the Statutory Health Insurance Contribution Rate Stabilization Act, stating it "imposes further burdens on hospitals. Instead of reducing bureaucracy and refocusing on patient care, the reform saddles already overburdened hospitals with even more documentation requirements, excessive budget cuts, and financial risks."
Looking ahead to 2026, RHON-KLINIKUM expects revenues of EUR 1.7 billion (plus or minus 5%) and EBITDA between EUR 110 million and EUR 125 million. The company also anticipates moderate improvements in case numbers and cost weights. However, the forecast is clouded by uncertainties from the Hospital Reform Adjustment Act (KHAG) and the SHI Contribution Rate Stabilisation Act (GKV-BStabG), which aim to improve quality and efficiency but may increase financial pressure on hospitals in the short term.
The company notes that ongoing global crises, supply chain issues, and market volatility could further impact operations. The full interim report is available on the company's website. As a major healthcare provider in Germany, RHON-KLINIKUM operates five facilities, including university hospitals in Giessen and Marburg, and employs over 19,100 staff, treating approximately 938,000 patients annually.
